Gonçalves, Gabriela M <br/><br/>
Antihyperalgesic effect of [(±)-(2,4,6-cis)-4-chloro-6-(naphthalen-1-yl)-tetrahydro-2H-pyran-2-yl]methanol: participation of the NO/cGMP/KATP pathway and κ-opioid receptor.  [electronic resource] 

 -  Behavioural pharmacology  09 2016 
 - 506-15 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5849 
<br/><br/><label>Standard No.: </label>10.1097/FBP.0000000000000238  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetic Acid--administration & dosage<br/>Administration, Oral<br/>Analgesics--administration & dosage<br/>Animals<br/>Cyclic GMP--metabolism<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drug Tolerance<br/>Hyperalgesia--drug therapy<br/>KATP Channels--metabolism<br/>Male<br/>Mice<br/>Morphine--administration & dosage<br/>Naphthalenes--administration & dosage<br/>Nitric Oxide--metabolism<br/>Pain Measurement<br/>Pyrans--administration & dosage<br/>Receptors, Opioid, kappa--metabolism